Cardioplegia Products

Cardioplegia delivery sets and a cardioplegia heat exchanger for the delivery of cardioplegic solution

Cardioplagia Image

Covid-19 Temporary Indications

To address the COVID-19 public health emergency, the U.S. Food and Drug Administration temporarily expanded the availability of devices used in extracorporeal membrane oxygenation therapy. Select LivaNova ACS and cardiopulmonary products are currently indicated for ECMO therapy beyond 6 hours.